These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationship of blood pressure and cardiovascular disease risk factors in normotensive middle-aged men. Pei D; Chen YL; Tang SH; Wu CZ; Lin JD; Chang YL; Hsu CH; Wang CY; Wang K; Wang JY Medicine (Baltimore); 2011 Sep; 90(5):344-349. PubMed ID: 21857368 [TBL] [Abstract][Full Text] [Related]
5. Prognostic interactions between cardiovascular risk factors. Vishram JK Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126 [TBL] [Abstract][Full Text] [Related]
6. Levels of Systolic and Diastolic Blood Pressure and Their Relation to Incident Metabolic Syndrome. Jung JY; Oh CM; Choi JM; Ryoo JH; Chung PW; Hong HP; Park SK Cardiology; 2019; 142(4):224-231. PubMed ID: 31302649 [TBL] [Abstract][Full Text] [Related]
7. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes. Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502 [TBL] [Abstract][Full Text] [Related]
8. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)]. Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214 [TBL] [Abstract][Full Text] [Related]
9. Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study. Dehghan A; Jahangiry L; Khezri R; Jafari A; Pezeshki B; Rezaei F; Aune D BMC Endocr Disord; 2024 Jun; 24(1):95. PubMed ID: 38915041 [TBL] [Abstract][Full Text] [Related]
10. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study. Ramezankhani A; Azizi F; Hadaegh F Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143 [TBL] [Abstract][Full Text] [Related]
11. The association of homocysteine with metabolic syndrome in a community-dwelling population: homocysteine might be concomitant with metabolic syndrome. Wang X; Ye P; Cao R; Yang X; Xiao W; Zhang Y; Bai Y; Wu H PLoS One; 2014; 9(11):e113148. PubMed ID: 25401978 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study. Stojisavljević D; Janković J; Erić M; Marinković J; Janković S J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):568-574. PubMed ID: 29097061 [TBL] [Abstract][Full Text] [Related]
13. The differences of metabolic syndrome in elderly subgroups: A special focus on young-old, old-old and oldest old. Chuang TJ; Huang CL; Lee CH; Hsieh CH; Hung YJ; Hung CF; Liang YJ; Chen YL; Hsia TL; Pei D Arch Gerontol Geriatr; 2016; 65():92-7. PubMed ID: 27016645 [TBL] [Abstract][Full Text] [Related]
14. Association between cumulative metabolic risk exposure and cardiovascular disease: a nationwide cohort of over 3.6 million young adults. Lee H; Rhee TM; Park HE; Han K; Choi SY Eur J Prev Cardiol; 2024 Aug; 31(10):1288-1300. PubMed ID: 38421612 [TBL] [Abstract][Full Text] [Related]
15. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study. Mansourian M; Babahajiani M; Jafari-Koshki T; Roohafza H; Sadeghi M; Sarrafzadegan N Metab Syndr Relat Disord; 2019 Sep; 17(7):362-366. PubMed ID: 31188051 [No Abstract] [Full Text] [Related]
16. Impact of blood pressure and other components of the metabolic syndrome on the development of cardiovascular disease. Kang G; Guo L; Guo Z; Hu X; Wu M; Zhou Z; Zhou H; Liu S; Chen F Circ J; 2010 Mar; 74(3):456-61. PubMed ID: 20057161 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of metabolic syndrome in a middle-aged and elderly population with prehypertension in Tianjin. Yao W; Sun Y; Wang X; Si Q; Chen H; Wan Z Clin Exp Hypertens; 2015; 37(5):369-74. PubMed ID: 25496289 [TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. Maggi S; Noale M; Gallina P; Bianchi D; Marzari C; Limongi F; Crepaldi G; J Gerontol A Biol Sci Med Sci; 2006 May; 61(5):505-10. PubMed ID: 16720749 [TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction. García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860 [TBL] [Abstract][Full Text] [Related]
20. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS). Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N J Atheroscler Thromb; 2009 Aug; 16(4):380-7. PubMed ID: 19672033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]